Side-by-side financials for CRMD and LLY. Every figure below comes from audited SEC filings and refreshed market data.
| Metric | CRMD | LLY |
|---|---|---|
| Market cap | - | $1.067 T |
| US-listed rank | - | #11 |
| Revenue (latest FY) | $311.71M | $65.18B |
| Net income (latest FY) | $163.06M | $20.64B |
| Net margin | 52.3% | 31.7% |
| P/E (trailing FY) | - | 51.7 |
| SEC filings | 1,001 | 989 |
In their latest fiscal years, CorMedix Inc. reported $311.71M in revenue while ELI LILLY & Co reported $65.18B.
Full pages: CorMedix Inc. and ELI LILLY & Co, or browse the full rankings.